DB
QTTB icon

Danske Bank’s Q32 Bio QTTB Stock Holding History

Danske Bank’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Hold
1
– – ﹤0.01% 1062
2026
Q1 		$6 Hold
1
– – ﹤0.01% 1098
2025
Q4 		$3 Hold
1
– – ﹤0.01% 1530
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1474
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1523
2025
Q1 		$2 Hold
1
– – ﹤0.01% 1349
2024
Q4 		$3 Hold
1
– – ﹤0.01% 1372
2024
Q3 		$45 Buy
+1
New +$37 ﹤0.01% 1478

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Danske Bank's QTTB Position: Q2 2026 in Review

Danske Bank held its Q32 Bio (QTTB) position steady in Q2 2026 at 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Danske Bank first reported a position in QTTB in Q3 2024 and has held it in 8 quarters since. The position peaked at $45 in Q3 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Danske Bank held 1 share of Q32 Bio worth $13 as of Q2 2026.
  • Danske Bank left its Q32 Bio share count unchanged in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1062 holding.
  • Danske Bank first reported a position in Q32 Bio in Q3 2024 and has held it in 8 quarters since.
  • Danske Bank's Q32 Bio position peaked at $45 in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.